This site is intended for healthcare professionals

Phase III REVEAL 1 trial of VGX 3100 meets endpoint in HPV-16/18-associated cervical squamous intraepithelial lesions.- Inovio

Read time: 1 mins
Last updated:4th Mar 2021
Published:3rd Mar 2021
Condition: Cervical Dysplasia
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest